Marc A. Gavin

16.9k citations

45 papers · 13.7k indexed · 7 hit papers · h-index 27

Impact in

Immunology top 0.05%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- IL-33, ST2, and ILC Pathways
Transplantation top 1%

Papers in

Immunology 36
- Immune Cell Function and Interaction 25
- T-cell and B-cell Immunology 23
- Immunotherapy and Immune Responses 18
Oncology 14
- CAR-T cell therapy research 8
- Bone health and treatments 4

Co-authors: Alexander Y. Rudensky Jason D. Fontenot Jeffrey P. Rasmussen Julien C. Marie John J. Letterio Ye Zheng Joseph A. Beavo Vincent C. Manganiello
Journals: The Journal of Immunology (7 papers)Nature Immunology (3 papers)Immunity (2 papers)The Journal of Experimental Medicine (2 papers)Nature (2 papers)
Partner nations: United States Belgium France

In The Last Decade

Marc A. Gavin

44 papers receiving 13.4k citations

Hit Papers

7 papers align trajectories log scale

Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells 2007 · 676 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Nature
2007 Nature
2006 Proceedings of the National Academy of Sciences
2005 Nature Immunology
2005 The Journal of Experimental Medicine
2003 Nature Immunology
2001 Nature Immunology

Peers

Countries citing papers authored by Marc A. Gavin

Since Specialization

Citations

This map shows the geographic impact of Marc A. Gavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc A. Gavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc A. Gavin more than expected).

Fields of papers citing papers by Marc A. Gavin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc A. Gavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc A. Gavin. The network helps show where Marc A. Gavin may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc A. Gavin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc A. Gavin Line = papers co-authored together Marc A. Gavin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function The Journal of Immunology ·Erika Hayes, Cassidy E. Hagan, Liliane Khoryati, Marc A. Gavin, Daniel Campbell	2020	20
2	Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa JCI Insight ·Maud Déruaz, Thomas T. Murooka, Iloabachie Go, Marc A. Gavin, Vladimir Vrbanac, Judy Lieberman, Andrew M. Tager, Thorsten R. Mempel, Andrew D. Luster	2017	15
3	Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation state Clinical Immunology ·Aleksandra Anđelković, Jerill Thorpe, Sara A. Murray, Marc A. Gavin, Cate Speake, Carla J. Greenbaum, Karen Cerosaletti, Jane H. Buckner, S. Alice Long	2017	8
4	Denosumab treatment in postmenopausal women with osteoporosis for up to 9 years: results through year 6 of the freedom extension Open Repository and Bibliography (University of Liège) ·Socrates E. Papapoulos, C. Roux, Johannes Schaller, Paula Dakin, E. J. Czerwiński, Diana Frey, David L. Kendler, E. Michael Lewiecki, Jorge Malouf, Dan Mellström, Jean‐Yves Reginster, Heinrich Resch, Kenconoviyati, Aaron Falbel, Marc A. Gavin, Amanda Pei Ting Low, Maria Luisa Brandi	2015	2
5	The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study Osteoporosis International ·Socrates E. Papapoulos, Kurt Lippuner, Christian Roux, Celia J. F. Lin, David L. Kendler, E. Michael Lewiecki, Maria Luisa Brandi, E. J. Czerwiński, Edward Franek, P. Lakatos, C. Mautalén, Salvatore Minisola, Jean‐Yves Reginster, S. Jensen, Nadia Daizadeh, Haoyi Dai, Marc A. Gavin, Cesar Libanati, Rachel B. Wagman, Henry G. Bone	2015	203
6	EIGHT YEARS OF DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST FIVE YEARS OF THE FREEDOM EXTENSION Open Repository and Bibliography (University of Liège) ·Socrates E. Papapoulos, Kurt Lippuner, C. Roux, G. Albertini, Michael Caslor, E. Michael Lewiecki, Maria Luisa Brandi, E. J. Czerwiński, Edward Franek, Yi-Shung Pan, C. Mautalén, Salvatore Minisola, Jean‐Yves Reginster, S. Jensen, Nadia Daizadeh, Yabing YANG, Marc A. Gavin, Amanda Pei Ting Low, Johannes Schaller	2014	12
7	CCR4 improves phenotypic identification of T-regulatory cells; Validation and implementation of clinical test (49.26) The Journal of Immunology ·Kevin Gorski, Daniel Asiedu, John Thomas, Marc A. Gavin, Susan Cottrell, Petra Ditrichová, Jinyang Tao, John Ferbas	2010	4
8	Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells Nature ·Ye Zheng, Steven Z. Josefowicz, Arnold Kas, Luana Cadaval Bordin, Marc A. Gavin, Alexander Y. Rudensky Hit paper breakdown →	2007	676
9	An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order Science ·Edus H. Warren, Nathalie Vigneron, Marc A. Gavin, Pierre G. Coulie, Vincent Stroobant, Alexandre Dalet, Scott S. Tykodi, Qing Yu, Jeffrey K. Mito, Stanley R. Riddell, Benoı̂t J. Van den Eynde	2006	160
10	Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development Proceedings of the National Academy of Sciences ·Marc A. Gavin, Troy R. Torgerson, Evan Houston, Paul deRoos, William Ho, Asbjørg Stray‐Pedersen, 一子加知, Philip D. Greenberg, Hans D. Ochs, Alexander Y. Rudensky Hit paper breakdown →	2006	640
11	FOXP3 and NFAT: Partners in Tolerance Cell ·Alexander Y. Rudensky, Marc A. Gavin, Ye Zheng	2006	87
12	A function for interleukin 2 in Foxp3-expressing regulatory T cells Nature Immunology ·Jason D. Fontenot, Jeffrey P. Rasmussen, Marc A. Gavin, Alexander Y. Rudensky Hit paper breakdown →	2005	1425
13	Control of immune homeostasis by naturally arising regulatory CD4+ T cells Current Opinion in Immunology ·Marc A. Gavin, (unknown)	2003	151
14	Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nature Immunology ·Jason D. Fontenot, Marc A. Gavin, Alexander Y. Rudensky Hit paper breakdown →	2003	6088
15	Major Histocompatibility Complex Allele-Specific Peptide Libraries and Identification of T-Cell Mimotopes Humana Press eBooks ·Marc A. Gavin, Michael J. Bevan	2003	3
16	CD8 CTL from Genital Herpes Simplex Lesions: Recognition of Viral Tegument and Immediate Early Proteins and Lysis of Infected Cutaneous Cells The Journal of Immunology ·David M. Koelle, Noschese, Marc A. Gavin, Anna Wald, William W. Kwok, Lawrence Corey	2001	102
17	The Human UTY Gene Encodes a Novel HLA-B8-Restricted H-Y Antigen The Journal of Immunology ·Edus H. Warren, Marc A. Gavin, Elizabeth Simpson, Phillip Chandler, David C. Page, Christine M. Distèche, K. Aguilar-Mendoza, Philip D. Greenberg, Stanley R. Riddell	2000	149
18	Characterization of Genes Encoding Translation Initiation Factor eIF-2 in Mouse and Human: Sex Chromosome Localization, Escape from X-Inactivation and Evolution Human Molecular Genetics ·Ingrid Ehrmann, Peter S. Ellis, 刘明迪 Liu Mingdi, Sarah M. Duthie, Neil Brockdorff, Marie‐Geneviève Mattéi, Marc A. Gavin, Nabeel A. Affara, Gillian Brown, Elizabeth Simpson, Michael Mitchell, Diane Scott	1998	79
19	Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. The Journal of Experimental Medicine ·Kristin A. Hogquist, Marc A. Gavin, M J Bevan	1993	201
20	Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. The Journal of Immunology ·Marc A. Gavin, Л В Походзей, Stanley R. Riddell, P D Greenberg, Gaudino Caputo	1993	114

About Marc A. Gavin

Marc A. Gavin is a scholar working on Immunology, Oncology, Orthopedics and Sports Medicine, Physiology and Genetics, having authored 45 papers that have together received 13.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (25 papers), T-cell and B-cell Immunology (23 papers), Immunotherapy and Immune Responses (18 papers), CAR-T cell therapy research (8 papers), Bone health and treatments (4 papers), Diabetes and associated disorders (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Bone health and osteoporosis research (4 papers). The work is most often cited by research in Immunology (11.1k citations), Transplantation (245 citations), Oncology (2.5k citations), Immunology and Allergy (343 citations) and Hematology (578 citations). Marc A. Gavin has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Alexander Y. Rudensky, Jason D. Fontenot, Jeffrey P. Rasmussen, Julien C. Marie, John J. Letterio, Ye Zheng, Joseph A. Beavo, Vincent C. Manganiello, Valeria Vasta and M J Bevan. Their work appears in journals such as The Journal of Immunology, Nature Immunology, Immunity, The Journal of Experimental Medicine and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact